Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
3.060
-0.130 (-4.08%)
Dec 27, 2024, 4:00 PM EST - Market closed
Zentalis Pharmaceuticals Market Cap
Zentalis Pharmaceuticals has a market cap or net worth of $218.07 million as of December 27, 2024. Its market cap has decreased by -75.96% in one year.
Market Cap
218.07M
Enterprise Value
-129.91M
1-Year Change
-75.96%
Ranking
Category
Stock Price
$3.06
Market Cap Chart
Since April 3, 2020, Zentalis Pharmaceuticals's market cap has increased from $129.95M to $218.07M, an increase of 67.81%. That is a compound annual growth rate of 11.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2024 | 227.34M | -78.80% |
| Dec 29, 2023 | 1.07B | -6.72% |
| Dec 30, 2022 | 1.15B | -69.82% |
| Dec 31, 2021 | 3.81B | 80.54% |
| Dec 31, 2020 | 2.11B | 1,523.25% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Heron Therapeutics | 240.31M |
| Anika Therapeutics | 239.16M |
| Aurora Cannabis | 234.03M |
| BGM Group | 233.06M |
| Precigen | 229.96M |
| DiaMedica Therapeutics | 224.92M |
| Perspective Therapeutics | 219.66M |
| Nautilus Biotechnology | 217.23M |